4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride

4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride 구조식 이미지
카스 번호:
633-59-0
상품명:
4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride
동의어(영문):
Ciatyl;Sordenac;CLOPENTHIXOL DIHYDROCHLORIDE;alpha-Clopenthixol dihydrochloride;Clopenthixol Dihydrochloride, Trans;Chlorperphenthixene dihydrochloride;4-[3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl]-1-piperazineethanol dihydrochloride;4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride;2-(4-(3-(2-Chloro-9H-thioxanthen-9-ylidene)propyl)piperazin-1-yl)ethanol dihydrochloride
CBNumber:
CB9922589
분자식:
C22H27Cl3N2OS
포뮬러 무게:
473.88658
MOL 파일:
633-59-0.mol

4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride 속성

녹는점
250-260° (dec)
저장 조건
Sealed in dry,Room Temperature
용해도
물에 매우 잘 녹습니다. 에탄올(96%)에 난용성; 에테르에는 아주 약간 용해됩니다.

안전

독성 LD50 in male mice (mg/kg): 111 i.v. (Lassen)

4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride C화학적 특성, 용도, 생산

화학적 성질

An off-white, granular powder.

용도

Dopamine receptor antagonist; neuroleptic.

4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride 준비 용품 및 원자재

원자재

준비 용품


4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride 공급 업체

글로벌( 10)공급 업체
공급자 전화 이메일 국가 제품 수 이점
Alfa Chemistry
+1-5166625404
Info@alfa-chemistry.com United States 21317 58
LEAP CHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 24738 58
Alfa Chemistry 1-516-6625404
support@alfa-chemistry.com United States 9171 60
Aikon International Limited 025-66113011 13155353615
qzhang@aikonchem.com China 15396 58
Zhuhai Anzhe Biotechnology Co,Ltd. 13570603050
793448631@qq.com China 3015 58
Hangzhou Bingochem Co., Ltd. 0571-87632989
sales@bingochem.com China 21673 58

4-[3-(2-chloro-9H-thioxanthen-9-ylidene)propyl]piperazine-1-ethanol dihydrochloride 관련 검색:

Copyright 2019 © ChemicalBook. All rights reserved